Hassan R - Search Results

1

Malignant mesothelioma of the inguinal canal with an unusually long survival.

Walshe JM, Gal A, Murray DR, Premkumar A, Berman D, Hassan R. Walshe JM, et al. Among authors: hassan r. Am J Clin Oncol. 2008 Jun;31(3):306-7. doi: 10.1097/01.coc.0000204404.36736.69. Am J Clin Oncol. 2008. PMID: 18525312 Free PMC article. No abstract available.

2

Humoral immune response to mesothelin in mesothelioma and ovarian cancer patients.

Ho M, Hassan R, Zhang J, Wang QC, Onda M, Bera T, Pastan I. Ho M, et al. Among authors: hassan r. Clin Cancer Res. 2005 May 15;11(10):3814-20. doi: 10.1158/1078-0432.CCR-04-2304. Clin Cancer Res. 2005. PMID: 15897581

3

Detection and quantitation of serum mesothelin, a tumor marker for patients with mesothelioma and ovarian cancer.

Hassan R, Remaley AT, Sampson ML, Zhang J, Cox DD, Pingpank J, Alexander R, Willingham M, Pastan I, Onda M. Hassan R, et al. Clin Cancer Res. 2006 Jan 15;12(2):447-53. doi: 10.1158/1078-0432.CCR-05-1477. Clin Cancer Res. 2006. PMID: 16428485

4

Current treatment options and biology of peritoneal mesothelioma: meeting summary of the first NIH peritoneal mesothelioma conference.

Hassan R, Alexander R, Antman K, Boffetta P, Churg A, Coit D, Hausner P, Kennedy R, Kindler H, Metintas M, Mutti L, Onda M, Pass H, Premkumar A, Roggli V, Sterman D, Sugarbaker P, Taub R, Verschraegen C. Hassan R, et al. Ann Oncol. 2006 Nov;17(11):1615-9. doi: 10.1093/annonc/mdl060. Epub 2006 Apr 6. Ann Oncol. 2006. PMID: 16600983 Free article.

5

Phase I study of SS1P, a recombinant anti-mesothelin immunotoxin given as a bolus I.V. infusion to patients with mesothelin-expressing mesothelioma, ovarian, and pancreatic cancers.

Hassan R, Bullock S, Premkumar A, Kreitman RJ, Kindler H, Willingham MC, Pastan I. Hassan R, et al. Clin Cancer Res. 2007 Sep 1;13(17):5144-9. doi: 10.1158/1078-0432.CCR-07-0869. Clin Cancer Res. 2007. PMID: 17785569 Clinical Trial.

6

Patients with peritoneal mesothelioma lack epidermal growth factor receptor tyrosine kinase mutations that would make them sensitive to tyrosine kinase inhibitors.

Kalra N, Ashai A, Xi L, Zhang J, Avital I, Raffeld M, Hassan R. Kalra N, et al. Among authors: hassan r. Oncol Rep. 2012 Jun;27(6):1794-800. doi: 10.3892/or.2012.1725. Epub 2012 Mar 15. Oncol Rep. 2012. PMID: 22426987 Free PMC article.

7

A novel nomogram for peritoneal mesothelioma predicts survival.

Schaub NP, Alimchandani M, Quezado M, Kalina P, Eberhardt JS, Hughes MS, Beresnev T, Hassan R, Bartlett DL, Libutti SK, Pingpank JF, Royal RE, Kammula US, Pandalai P, Phan GQ, Stojadinovic A, Rudloff U, Alexander HR, Avital I. Schaub NP, et al. Among authors: hassan r. Ann Surg Oncol. 2013 Feb;20(2):555-61. doi: 10.1245/s10434-012-2651-5. Epub 2012 Dec 12. Ann Surg Oncol. 2013. PMID: 23233234 Free PMC article.

8

Clinical and pathological features are still the best determinants of prognosis in mesothelioma.

Miller AC, Hassan R. Miller AC, et al. Among authors: hassan r. Oncology (Williston Park). 2012 Dec;26(12):1176, 1178, 1180. Oncology (Williston Park). 2012. PMID: 23413598 Free PMC article. No abstract available.

9

Mesothelin Immunotherapy for Cancer: Ready for Prime Time?

Hassan R, Thomas A, Alewine C, Le DT, Jaffee EM, Pastan I. Hassan R, et al. J Clin Oncol. 2016 Dec;34(34):4171-4179. doi: 10.1200/JCO.2016.68.3672. Epub 2016 Oct 31. J Clin Oncol. 2016. PMID: 27863199 Free PMC article. Review.

10

CTLA-4 blockade in mesothelioma: ineffective or reason for optimism?

Thomas A, Hassan R. Thomas A, et al. Among authors: hassan r. Lancet Oncol. 2017 Sep;18(9):1150-1151. doi: 10.1016/S1470-2045(17)30511-9. Epub 2017 Jul 17. Lancet Oncol. 2017. PMID: 28729153 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,199 results

Search Page

Filters